AAIC 2025 Conference Symposium Agenda

Inhibition of β-Amyloid Oligomer Neurotoxicity with Oral Valiltramiprosate

Dr. Cohen [00:00] Chair’s Welcome & Program Objectives
Dr. Gandy [07:42] Pathogenic Role of Beta Amyloid Oligomers in AD
Dr. Ono [20:20] Insights into Mechanism of Action of Valiltramiprosate
Dr. Geerts [34:35] QSP Analysis of Inhibition of Amyloid Oligomer Formation by Valiltramiprosate
Dr. Hey [45:45] Disease Modifying Effects of Valiltramiprosate in Early Symptomatic AD
Dr. Cohen [1:03:20] Questions & Answers
For privacy reasons Vimeo needs your permission to be loaded. For more details, please see our Privacy Policy.